Skip to main content
Use count
91

Hints of Progress in the Ebola Fight

Dina Fine Maron Scientific American
The number of Ebola cases appear to be dropping in Liberia—but what will it take to stamp out the disease?

Barbie Reincarnate – Only This Time She Looks Human

Kalliopi Monoyios Scientific American
Artist Nickolay Lamm, inspired by his own and his relative’s struggles with body-image issues, wondered what Mattel’s Barbie doll would look like if she weren’t such an anatomical freak.

Supercharging Brown Fat to Battle Obesity

Melinda Wenner Moyer Scientific American
There is no doubt that an unhealthy diet and sedentary lifestyle are the two chief drivers of the obesity epidemic, but many researchers are confident that they will eventually hit on specific brown fat–based treatments, although most admit that such interventions most likely are 10 years away at least.

How Voices Carry Signals of Sexual Intent

Jesse Bering Scientific American
Listeners prefer and respond more favorably (or in technical terms, in a more “proceptive” fashion) to opposite-sex voices that contain these special subtle acoustics

Music Changes the Way You Think

Daniel A. Yudkin and Yaacov Trope Scientific American
Different music encourages different frames of mind. That music can move us is no surprise; it's the point of the art form, after all. What's new here is the manner in which the researchers have quantified in fine-grained detail the cognitive ramifications of unpacked melodic compounds. This investigation of music's building blocks may be more relevant than you suppose.

Antibiotic Resistance Revitalizes Century-Old Virus Therapy

Sara Reardon and Nature magazine Scientific American
Denied access to some of the best antibiotics developed in the West the Soviet Union invested heavily in the use of bacteriophages — viruses that kill bacteria — to treat infections. Now, faced with the looming spectre of antibiotic resistance, Western researchers and governments are giving phages a serious look. Pharmaceutical companies remain reluctant to get on board because phage therapy, nearly a century old, would be difficult claim intellectual property.
Subscribe to Scientific American